LRCX +8.5%: One-Day Bounce Hasn’t Reversed the Trend

I don’t read today’s +8.49% move to $241.28 as a confirmed momentum reversal, and it does not change my view. LRCX is still down 28.4% over three months and 19.9% over one month, and sits 44.3% below its 52-week high; one session cannot erase that deterioration. The fundamental backdrop is strong: Q3 revenue grew 54.4%, free cash flow rose 103.3%, and FY2027 consensus EPS is $9.650, up 67.5%. At 25.0x estimated FY2027 earnings, valuation is not prohibitive, while the current 36.0x trailing P/E reflects substantial growth expectations. But Q3 EPS beat estimates by only 0.9%, so the latest results do not independently confirm accelerating upside momentum. I have no position; I’ll stay out until the price trend improves more convincingly.